Suppr超能文献

[应用AdEasy-1系统构建携带人去甲肾上腺素转运体基因的复制缺陷型重组腺病毒载体及其表达]

[Construction and expression of replication-deficient recombinant adenovirus vector with hNET gene by adeasy-1 system].

作者信息

Jia Zhi-yun, Ou Xiao-hong, Wei Hai-yan, Deng Hou-fu, Huang Rui, Wang Jin-rong, Zhang Shi-qiong

机构信息

Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):523-6.

Abstract

OBJECTIVE

To construct and identify the recombinant replication deficient adenovirus vector which codes for human Norepinephrine Transporter (hNET) gene by using the method of homogenous recombination in bacteria.

METHODS

hNET gene was obtained from the recombinant plasmid pCMV5 via Kpn I + Xba I digestion, and subcloned into E1 deleted expression plasmid pAdtrack-CMV shuttle vector, forming transfer vector pAdtrack-CMV-hNET. Then it was linearized with Pme I followed by homologous recombination with bone plasmid pAdEasy-1 in BJ5183 cells to generate recombinant plasmid Ad-hNET. The DNA of identified Ad-hNET was digested with Pac I and transfected to HEK293 cells by liposome-mediated method to package recombinant adenovirus. The PCR technique was applied to detect the target gene and Western Blotting to verify the expression of hNET. The titre of the Ad-hNET was measured with the aid of green fluorescence protein (GFP) expression after multiplication and purification.

RESULTS

By sequencing, it was confirmed that the product was the gene of hNET. PCR test, restriction endonuclease digestion and Western Blotting confirmed the successful construction of the recombinants Ad-hNET. The titre of purified recombinant adenovirus Ad-hNET was 1.2 X 10(10) pfu/mL.

CONCLUSION

The recombinant adenovirus with the hNET gene was constructed successfully. It will be helpful for the further investigation of its potentiality to be applied in the tumors targeted therapeutic strategy.

摘要

目的

利用细菌内同源重组法构建并鉴定编码人去甲肾上腺素转运体(hNET)基因的重组复制缺陷型腺病毒载体。

方法

通过Kpn I + Xba I酶切从重组质粒pCMV5中获得hNET基因,并亚克隆到E1缺失的表达质粒pAdtrack-CMV穿梭载体中,形成转移载体pAdtrack-CMV-hNET。然后用Pme I将其线性化,随后在BJ5183细胞中与骨架质粒pAdEasy-1进行同源重组,产生重组质粒Ad-hNET。用Pac I酶切鉴定后的Ad-hNET的DNA,通过脂质体介导法转染至HEK293细胞中以包装重组腺病毒。应用PCR技术检测目的基因,并用蛋白质免疫印迹法验证hNET的表达。在增殖和纯化后,借助绿色荧光蛋白(GFP)表达测定Ad-hNET的滴度。

结果

通过测序证实产物为hNET基因。PCR检测、限制性内切酶消化和蛋白质免疫印迹法证实重组体Ad-hNET构建成功。纯化后的重组腺病毒Ad-hNET的滴度为1.2×10(10) pfu/mL。

结论

成功构建了携带hNET基因的重组腺病毒。这将有助于进一步研究其在肿瘤靶向治疗策略中的应用潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验